A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's

Clinical trial NCT03943264 · COMPLETED

Trial details

NCT number: NCT03943264
Sponsor: Inmune Bio, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-11-20
Primary completion: 2021-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.